Headquartered in Dublin, OH Fiscal year ends June NYSE: CAH cardinalhealth.com
Cardinal Health is a diversified healthcare services and products company operating through multiple segments. Its Pharmaceutical and Specialty Solutions segment is one of the largest pharmaceutical distributors in the United States, providing brand, generic, and specialty pharmaceuticals to retail pharmacies, hospitals, and other healthcare providers. The Global Medical Products and Distribution (GMPD) segment manufactures and distributes medical, surgical, and laboratory products globally under the Cardinal Health brand and other labels. The company also operates three additional segments grouped as 'Other': Nuclear and Precision Health Solutions (operating nuclear pharmacies and manufacturing nuclear imaging agents), at-Home Solutions (providing home healthcare products and services directly to patients), and OptiFreight Logistics (offering freight management services to healthcare systems). Cardinal Health has been actively expanding through physician practice acquisitions including Integrated Oncology Network, GI Alliance, Urology America, Solaris Health, and Advanced Diabetes Supply Group, and has recently acquired Strive Medical and announced acquisition of AdaptHealth's Diabetes Health business. Updated
Cardinal Health closed at $253.71, a record that clears its early September peak by 2.05% and caps a climb from $154.58 a year ago. The $58.7 billion distributor has now taken out every high set during its spring stall.
A 4% intraday climb to $241.19 adds roughly $2.2 billion to Cardinal Health's $55.8 billion market value, a sizable single session for a low-drama drug distributor. Whether it holds into the close is the thing to watch.
Markets turned south again Wednesday as surging yields and geopolitical fears rattled investors, but Wall Street analysts spotted opportunity and danger in names like Baidu, Klarna, Honeywell Aerospace, and Dollar Tree that…
Kiplinger’s Personal Finance May 2026 letter makes it clear that if you are looking for yield, the door is wide open across the entire risk spectrum. We are seeing a massive spread,…
Roughly a year ago, 24/7 Wall St. ran a piece titled Forget UnitedHealth. Cardinal Health Is the Best Healthcare Stock to Buy Right Now, arguing that Cardinal Health (NYSE: CAH | CAH…
William Blair launched coverage of Cardinal Health (NYSE:CAH | CAH Price Prediction) with an Outperform rating today, framing the pharma distributor as a durable franchise with specialty-led upside. The firm simultaneously initiated…
This morning’s jobs report landed hard. Nonfarm payrolls plunged by 92,000 jobs, shattering expectations of a 55,000 gain. Unemployment climbed to 4.4%, while average hourly earnings jumped 0.4% month-over-month — well above…
Rich Duprey Cardinal Health (NYSE: CAH | CAH Price Prediction) delivered a decisive second-quarter beat on February 5, 2026, with non-GAAP EPS of $2.63, surpassing the $2.38 consensus estimate by 10.5%. Revenue climbed 19%…
Joel South Cardinal Health (NYSE: CAH | CAH Price Prediction) delivered a commanding first quarter for fiscal 2026, beating both earnings and revenue expectations by wide margins while raising full-year guidance. The stock climbed…
Joel South Dividend investing stands out as a reliable path to building wealth because it turns company profits into a steady cash stream for shareholders. Unlike chasing high-growth stocks that can swing wildly with…
Live Updates Tuesday Wrap-up4:05pm ETThe Vanguard S&P 500 ETF closed at 590.16 Tuesday, up almost 1%. Don't Shop Shopify12:14pm ETOn the flip side, Phillip Securities analyst Helena Wang has downgraded Shopify (Nasdaq:…
Lock Them Up and Throw Away the Key Letting go of a losing stock is simple, but clinging to a winner — especially one that’s doubled, tripled, or quadrupled your initial investment…
These five top Buy-rated dividend stocks were among S&P 500's top performers so far this year and still offer strong total return potential.
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) has faced severe headwinds in 2025, with its stock plummeting over 50% from its April high. This decline was driven by a rare first-quarter earnings…
These four Dividend Aristocrats are far outperforming the S&P 500 so far this year. They still offer investors good entry points and may be total return home runs for 2025.
With all of the major indices making solid moves higher in 2024, we were very interested to see what the top prognosticators across Wall Street think is in store for 2025 as…
Dividend investing has proved to be a reliable source of income for investors while allowing for long-term generational wealth accumulation. Historically, dividend-paying stocks have generated far greater returns than non-payers, and done…
Cardinal Health is a diversified healthcare services and products company operating through multiple segments.
24/7 Wall St.'s 12-month price target for CAH is $305.16, rated Buy. The Wall Street consensus target is $270.47. CAH price prediction →
